
Canadian venture capital firm Quark Venture is to partner up with China’s GF Securities to launch a “largest of its …

Senior health officials may have to bar Gilead’s new hepatitis C pill Sovaldi from being funded on the NHS after …
NHS England has pulled the plug on a £50 million fund to advance innovation in the investigation and treatment of …
The Wellcome Trust is to launch a £200 million business that will invest in emerging healthcare and life sciences firms. …

